The global retinal disorder treatment market size is expected to reach USD 25.69 billion, expanding at a CAGR of 9.3% from 2023 to 2030. Growth in the market is fueled by the increasing prevalence of retinal disorders around the world and the unmet need for affordable and efficient treatments. Furthermore, improved funding by regulatory bodies for R&D associated with ocular disorders is expected to further drive market growth.
Retinal diseases are one of the leading causes of visual impairment among the global population. According to WHO, in 2022, a near or distant vision impairment affects at least 2.2 billion people worldwide. Nearly half of these cases, or around 1 billion, involved vision impairments that either could have been avoided or are still unaddressed. Factors such as changing lifestyles, increased life expectancy, and escalating prevalence of systemic diseases like hypertension and diabetes mellitus are the most common causes of retinal disorders. This demonstrates an unmet need among retinal disorder patients for treatment of the condition.
The rising geriatric population is acting as a driver for the market; age-related macular degeneration (AMD) is one of the leading causes of vision loss in people aged over 65 years. AMD is characterized by the degeneration of an area of the retina known as the macula, which is responsible for central vision. The growing elderly population is expected to create a wider patient pool for the treatment of AMD. For instance, according to a WHO report in 2021, by 2030, 1 in every 6 people in the world will be aged 60 years or over. Furthermore, over this period of time, the population aged over 60 years is expected to increase from 1 billion in 2020 to 1.4 billion.
The high cost associated with retinal disorder treatment poses a threat to the growth of the market. However, increasing efforts from key players operating in the market for developing new products for the enhancement of their product pipeline is expected to drive the market. For instance, in January 2022, Genentech’s Vabysmo was approved by the FDA, the first-in-class bispecific antibody for the treatment of wet age-related macular degeneration and diabetic macular edema. The launch of novel products is expected to propel market growth.
Retinal diseases are one of the leading causes of visual impairment among the global population. According to WHO, in 2022, a near or distant vision impairment affects at least 2.2 billion people worldwide. Nearly half of these cases, or around 1 billion, involved vision impairments that either could have been avoided or are still unaddressed. Factors such as changing lifestyles, increased life expectancy, and escalating prevalence of systemic diseases like hypertension and diabetes mellitus are the most common causes of retinal disorders. This demonstrates an unmet need among retinal disorder patients for treatment of the condition.
The rising geriatric population is acting as a driver for the market; age-related macular degeneration (AMD) is one of the leading causes of vision loss in people aged over 65 years. AMD is characterized by the degeneration of an area of the retina known as the macula, which is responsible for central vision. The growing elderly population is expected to create a wider patient pool for the treatment of AMD. For instance, according to a WHO report in 2021, by 2030, 1 in every 6 people in the world will be aged 60 years or over. Furthermore, over this period of time, the population aged over 60 years is expected to increase from 1 billion in 2020 to 1.4 billion.
The high cost associated with retinal disorder treatment poses a threat to the growth of the market. However, increasing efforts from key players operating in the market for developing new products for the enhancement of their product pipeline is expected to drive the market. For instance, in January 2022, Genentech’s Vabysmo was approved by the FDA, the first-in-class bispecific antibody for the treatment of wet age-related macular degeneration and diabetic macular edema. The launch of novel products is expected to propel market growth.
Retinal Disorder Treatment Market Report Highlights
- By type, the macular degeneration segment held the largest market share in 2022, which is attributable to its high prevalence, rising awareness about the disease, and promising pipeline products
- Eye drops dosage form segment is projected to grow at the fastest rate over the forecast period due to its high adoption and ease of use
- Hospital pharmacies held a dominant share of the distribution channel segment in 2022 due to the ease of access and availability of patient records
- North America dominated the global market in 2022 and is expected to grow considerably in the future, owing to the rising prevalence of retinal disorders and the increasing consumer awareness about retinal disorders
- A few of the key players include Regeneron Pharmaceuticals Inc., Shire (Takeda Pharmaceutical Company Limited), Graybug Vision, Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., and Genentech, Inc.
Table of Contents
Chapter 1 Methodology And Scope1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Retinal Disorder Treatment Market: Executive Summary
2.1 Market Outlook
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Retinal Disorder Treatment Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market
3.2 Epidemiology
3.2.1 Retinal Disorders
3.3 Market Dynamics
3.3.1 Market Drivers Analysis
3.3.1.1 Increasing Prevalence Of Target Diseases
3.3.1.2 Strong Pipeline
3.3.1.3 Increasing Geriatric Population
3.3.1.4 Rising Awareness Of Retinal Disorders
3.3.2 Market Restraint Analysis
3.3.2.1 High Cost Of Treatment Drugs
3.4 Penetration & Growth Prospect Mapping
3.5 Retinal Disorder Treatment: Market Analysis Tools
3.5.1 Industry Analysis - Porter’s
3.5.2 Pestle Analysis
3.5.3 Pipeline Analysis
3.5.4 Major Deals And Strategic Alliances
3.5.4.1 New Product Launch
3.5.4.2 Acquisition
3.5.4.3 Expansion
3.5.4.4 Partnerships
3.5.4.5 Marketing & Promotions
Chapter 4 Retinal Disorder Treatment Market: Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition And Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Retinal Disorder Treatment Market, By Type, 2018 To 2030
4.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
4.5.1 Macular Degeneration
4.5.1.1 Macular Degeneration Market, 2018 - 2030 (USD Million)
4.5.1.2 Dry Macular Degeneration
4.5.1.2.1 Dry Macular Degeneration Market, 2018 - 2030 (USD Million)
4.5.1.3 Wet Macular Degeneration
4.5.1.3.1 Wet Macular Degeneration Market, 2018 - 2030 (USD Million)
4.5.2 Diabetic Retinopathy
4.5.2.1 Diabetic Retinopathy Market, 2018 - 2030 (USD Million)
4.5.3 Others
4.5.3.1 Others Market, 2018 - 2030 (USD Million)
Chapter 5 Retinal Disorder Treatment Market: Segment Analysis, By Dosage Form, 2018 - 2030 (USD Million)
5.1 Definition And Scope
5.2 Dosage Form Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 To 2030
5.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
5.5.1 Gels
5.5.1.1 Gels Market, 2018 - 2030 (USD Million)
5.5.2 Eye Solutions & Suspensions
5.5.2.1 Eye Solutions Market, 2018 - 2030 (USD Million)
5.5.3 Capsules & Tablets
5.5.3.1 Capsules & Tablets Market, 2018 - 2030 (USD Million)
5.5.4 Eye Drops
5.5.4.1 Eye Drops Market, 2018 - 2030 (USD Million)
5.5.5 Ointments
5.5.5.1 Ointments Market, 2018 - 2030 (USD Million)
Chapter 6 Retinal Disorder Treatment Market: Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
6.1 Definition And Scope
6.2 Distribution Channel Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 To 2030
6.5 Market Size & Forecasts And Trend Analyses, 2018 To 2030
6.5.1 Hospital Pharmacy
6.5.1.1 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
6.5.2 Online Pharmacy
6.5.2.1 Online Pharmacy Market, 2018 - 2030 (USD Million)
6.5.3 Retail Pharmacy
6.5.3.1 Retail Pharmacy Market, 2018 - 2030 (USD Million)
Chapter 7 Retinal Disorder Treatment Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA
7.6 Market Size, & Forecasts, Trend Analysis, 2018 To 2030
7.7 North America
7.7.1 North America Retinal Disorder Treatment Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.7.2 U.S.
7.7.2.1 U.S. Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.7.2.2 Key Country Dynamics
7.7.2.3 Regulatory Framework
7.7.2.4 Competitive Scenario
7.7.2.5 Investments Scenario
7.7.3 Canada
7.7.3.1 Canada Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.7.3.2 Key Country Dynamics
7.7.3.3 Regulatory Framework
7.7.3.4 Competitive Scenario
7.7.3.5 Investments Scenario
7.8 Europe
7.8.1 Europe Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.2 Uk
7.8.2.1 Uk Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.2.2 Key Country Dynamics
7.8.2.3 Regulatory Framework
7.8.2.4 Competitive Scenario
7.8.2.5 Investments Scenario
7.8.3 Germany
7.8.3.1 Germany Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.3.2 Key Country Dynamics
7.8.3.3 Regulatory Framework
7.8.3.4 Competitive Scenario
7.8.3.5 Investments Scenario
7.8.4 Spain
7.8.4.1 Spain Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.4.2 Key Country Dynamics
7.8.4.3 Regulatory Framework
7.8.4.4 Competitive Scenario
7.8.4.5 Investments Scenario
7.8.5 France
7.8.5.1 France Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.5.2 Key Country Dynamics
7.8.5.3 Regulatory Framework
7.8.5.4 Competitive Scenario
7.8.5.5 Investments Scenario
7.8.6 Italy
7.8.6.1 Italy Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.6.2 Key Country Dynamics
7.8.6.3 Regulatory Framework
7.8.6.4 Competitive Scenario
7.8.6.5 Investments Scenario
7.8.7 Norway
7.8.7.1 Norway Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.7.3 Regulatory Framework
7.8.7.4 Competitive Scenario
7.8.7.5 Investments Scenario
7.8.8 Denmark
7.8.8.1 Denmark Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.8.2 Key Country Dynamics
7.8.8.3 Regulatory Framework
7.8.8.4 Competitive Scenario
7.8.8.5 Investments Scenario
7.8.9 Sweden
7.8.9.1 Sweden Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.8.9.2 Key Country Dynamics
7.8.9.3 Regulatory Framework
7.8.9.4 Competitive Scenario
7.8.9.5 Investments Scenario
7.9 Asia Pacific
7.9.1 Asia-Pacific Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.2 Japan
7.9.2.1 Japan Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.2.2 Key Country Dynamics
7.9.2.3 Regulatory Framework
7.9.2.4 Competitive Scenario
7.9.2.5 Investments Scenario
7.9.3 China
7.9.3.1 China Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.3.2 Key Country Dynamics
7.9.3.3 Regulatory Framework
7.9.3.4 Competitive Scenario
7.9.3.5 Investments Scenario
7.9.4 India
7.9.4.1 India Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.4.2 Key Country Dynamics
7.9.4.3 Regulatory Framework
7.9.4.4 Competitive Scenario
7.9.4.5 Investments Scenario
7.9.5 South Korea
7.9.5.1 South Korea Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.5.2 Key Country Dynamics
7.9.5.3 Regulatory Framework
7.9.5.4 Competitive Scenario
7.9.5.5 Investments Scenario
7.9.6 Thailand
7.9.6.1 Thailand Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.6.2 Key Country Dynamics
7.9.6.3 Regulatory Framework
7.9.6.4 Competitive Scenario
7.9.6.5 Investments Scenario
7.9.7 Australia
7.9.7.1 Australia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.9.7.2 Key Country Dynamics
7.9.7.3 Regulatory Framework
7.9.7.4 Competitive Scenario
7.9.7.5 Investments Scenario
7.10 Latin America
7.10.1 Latin America Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.10.2 Brazil
7.10.2.1 Brazil Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.10.2.2 Key Country Dynamics
7.10.2.3 Regulatory Framework
7.10.2.4 Competitive Scenario
7.10.2.5 Investments Scenario
7.10.3 Mexico
7.10.3.1 Mexico Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.10.3.2 Key Country Dynamics
7.10.3.3 Regulatory Framework
7.10.3.4 Competitive Scenario
7.10.3.5 Investments Scenario
7.10.4 Argentina
7.10.4.1 Argentina Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.10.4.2 Key Country Dynamics
7.10.4.3 Regulatory Framework
7.10.4.4 Competitive Scenario
7.10.4.5 Investments Scenario
7.11 MEA
7.11.1 MEA Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.11.2 South Africa
7.11.2.1 South Africa Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.11.2.2 Key Country Dynamics
7.11.2.3 Regulatory Framework
7.11.2.4 Competitive Scenario
7.11.2.5 Investments Scenario
7.11.3 Saudi Arabia
7.11.3.1 Saudi Arabia Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.11.3.2 Key Country Dynamics
7.11.3.3 Regulatory Framework
7.11.3.4 Competitive Scenario
7.11.3.5 Investments Scenario
7.11.4 UAE
7.11.4.1 UAE Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.11.4.2 Key Country Dynamics
7.11.4.3 Regulatory Framework
7.11.4.4 Competitive Scenario
7.11.4.5 Investments Scenario
7.11.5 Kuwait
7.11.5.1 Kuwait Retinal Disorder Treatment Market, 2018 - 2030 (USD Million)
7.11.5.2 Key Country Dynamics
7.11.5.3 Regulatory Framework
7.11.5.4 Competitive Scenario
7.11.5.5 Investments Scenario
Chapter 8 Retinal Disorder Treatment Market - Competitive Analysis
8.1 Recent Developments & Impact Analysis, By Key Market Participants
8.1.1 Ansoff Matrix
8.1.2 Heat Map Analysis
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List Of Key Distributors And Channel Partners
8.3.2 Key Customers
8.3.3 Key Company Market Share Analysis, 2022
8.4 Public Companies
8.4.1 Company Market Position Analysis
8.4.2 Company Market Share, By Region
8.4.3 Competitive Dashboard Analysis
8.4.3.1 Market Differentiators
8.5 Private Companies
8.5.1 List Of Key Emerging Companies
8.6 Company Profiles
8.6.1 Graybug Vision, Inc.
8.6.1.1 Company Overview
8.6.1.2 Product Benchmarking
8.6.1.3 Strategic Initiatives
8.6.2 Shire (Takeda Pharmaceutical Company Limited)
8.6.2.1 Company Overview
8.6.2.2 Financial Performance
8.6.2.3 Product Benchmarking
8.6.3 Regeneron Pharmaceuticals Inc.
8.6.3.1 Company Overview
8.6.3.2 Financial Performance
8.6.3.3 Product Benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 Acucela Inc.
8.6.4.1 Company Overview
8.6.4.2 Financial Performance
8.6.4.3 Product Benchmarking
8.6.5 Allergan Plc. (Abbvie Inc.)
8.6.5.1 Company Overview
8.6.5.2 Financial Performance
8.6.5.3 Product Benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 Pfizer, Inc.
8.6.6.1 Company Overview
8.6.6.2 Financial Performance
8.6.6.3 Product Benchmarking
8.6.7 Bayer Ag
8.6.7.1 Company Overview
8.6.7.2 Financial Performance
8.6.7.3 Product Benchmarking
8.6.7.4 Strategic Initiatives
8.6.8 Santen Pharmaceuticals Co. Ltd.
8.6.8.1 Company Overview
8.6.8.2 Financial Performance
8.6.8.3 Product Benchmarking
8.6.8.4 Strategic Initiatives
8.6.9 Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
8.6.9.1 Company Overview
8.6.9.2 Financial Performance
8.6.9.3 Product Benchmarking
8.6.9.4 Strategic Initiatives
8.6.10 Kubota Pharmaceutical Holdings Co., Ltd.
8.6.9.1 Company Overview
8.6.9.2 Financial Performance
8.6.9.3 Product Benchmarking
8.6.9.4 Strategic Initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 Global Retinal Disorder Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 3 Global Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 4 Global Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 5 Global Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 6 Global Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 7 North America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 9 North America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 10 North America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 11 North America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 12 U.S. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 13 U.S. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 14 U.S. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 15 U.S. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Canada Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 17 Canada Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 18 Canada Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 19 Canada Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 Europe Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 21 Europe Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 22 Europe Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 23 Europe Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 24 Europe Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 25 U.K. Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 26 U.K. Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 27 U.K. Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 28 U.K. Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Germany Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 30 Germany Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 31 Germany Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 32 Germany Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 France Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 34 France Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 35 France Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 36 France Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Italy Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 38 Italy Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 39 Italy Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 40 Italy Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 41 Spain Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 42 Spain Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 43 Spain Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 44 Spain Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 45 Denmark Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 46 Denmark Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 47 Denmark Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 48 Denmark Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 49 Sweden Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 50 Sweden Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 51 Sweden Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 52 Sweden Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 Norway Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 54 Norway Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 55 Norway Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 56 Norway Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 57 Asia Pacific Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 58 Asia Pacific Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 62 Japan Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 63 Japan Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 64 Japan Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 65 Japan Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 66 China Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 67 China Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 68 China Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 69 China Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 70 India Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 71 India Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 72 India Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 73 India Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 74 South Korea Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 75 South Korea Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 76 South Korea Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 77 South Korea Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 78 Thailand Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 79 Thailand Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 80 Thailand Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 81 Thailand Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 82 Australia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 83 Australia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 84 Australia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 85 Australia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 86 Latin America Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 87 Latin America Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 88 Latin America Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 89 Latin America Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 90 Latin America Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 91 Mexico Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 92 Mexico Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 93 Mexico Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 94 Mexico Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 95 Brazil Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 96 Brazil Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 97 Brazil Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 98 Brazil Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 99 Argentina Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 100 Argentina Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 101 Argentina Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 102 Argentina Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 103 MEA Retinal Disorder Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 104 MEA Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 105 MEA Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 106 MEA Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 107 MEA Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 108 South Africa Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 109 South Africa Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 110 South Africa Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 111 South Africa Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 112 Saudi Arabia Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 113 Saudi Arabia Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 114 Saudi Arabia Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 115 Saudi Arabia Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 116 UAE Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 117 UAE Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 118 Kuwait Retinal Disorder Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 119 Kuwait Macular Degeneration Market, By Type, 2018 - 2030 (USD Million)
Table 120 Kuwait Retinal Disorder Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
Table 121 Kuwait Retinal Disorder Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Information Procurement
Fig. 3 Primary Research Pattern
Fig. 4 Market Research Approaches
Fig. 5 Value Chain-Based Sizing & Forecasting
Fig. 6 Market Formulation & Validation
Fig. 7 Retinal Disorder Treatment Market Segmentation
Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
Fig. 11 Penetration & Growth Prospect Mapping
Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Market Penetration & Growth Prospect Mapping
Fig. 15 Retinal Disorder Treatment market: Type outlook and key takeaways
Fig. 16 Retinal Disorder Treatment market: Type movement analysis & market share 2022 & 2030
Fig. 17 Macular degeneration market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Diabetic retinopathy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Other types market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Retinal Disorder Treatment market: Dosage form outlook and key takeaways
Fig. 21 Retinal Disorder Treatment market: Dosage form movement analysis & market share 2022 & 2030
Fig. 22 Gels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Capsule and tablets market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Retinal Disorder Treatment market: Distribution channel outlook and key takeaways
Fig. 28 Retinal Disorder Treatment market: Distribution channel movement analysis & market share 2022 & 2030
Fig. 29 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Regional Marketplace: Key Takeaways
Fig. 33 Regional Outlook, 2022 & 2030
Fig. 34 Regional Market Dashboard
Fig. 35 Regional Market Place: Key Takeaways
Fig. 36 North America, SWOT Analysis
Fig. 37 Europe, SWOT Analysis
Fig. 38 Asia Pacific, SWOT Analysis
Fig. 39 Latin America, SWOT Analysis
Fig. 40 MEA, SWOT Analysis
Fig. 41 North America
Fig. 42 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 43 U.S.
Fig. 44 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 45 Canada
Fig. 46 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 47 Europe
Fig. 48 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 49 UK
Fig. 50 UK Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 51 Germany
Fig. 52 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 53 France
Fig. 54 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 55 Italy
Fig. 56 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 57 Spain
Fig. 58 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 59 Denmark
Fig. 60 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 61 Sweden
Fig. 62 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 63 Norway
Fig. 64 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 65 Asia Pacific
Fig. 66 Asia-Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 67 Japan
Fig. 68 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 69 China
Fig. 70 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 71 India
Fig. 72 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 73 Australia
Fig. 74 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 75 Thailand
Fig. 76 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 77 South Korea
Fig. 78 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 79 Latin America
Fig. 80 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 81 Brazil
Fig. 82 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 83 Mexico
Fig. 84 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 85 Argentina
Fig. 86 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 87 MEA
Fig. 88 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 89 South Africa
Fig. 90 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 91 Saudi Arabia
Fig. 92 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 93 UAE
Fig. 94 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 95 Kuwait
Fig. 96 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
Fig. 97 Strategy Mapping
Companies Mentioned
- Graybug Vision, Inc.
- Shire (Takeda Pharmaceutical Company Limited)
- Regeneron Pharmaceuticals Inc.
- Acucela Inc.
- Allergan Plc. (Abbvie Inc.)
- Pfizer, Inc.
- Bayer Ag
- Santen Pharmaceuticals Co. Ltd.
- Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
- Kubota Pharmaceutical Holdings Co., Ltd.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | February 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 12.57 Billion |
| Forecasted Market Value ( USD | $ 25.69 Billion |
| Compound Annual Growth Rate | 9.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
